These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients. Olbei M; Hautefort I; Modos D; Treveil A; Poletti M; Gul L; Shannon-Lowe CD; Korcsmaros T Front Immunol; 2021; 12():629193. PubMed ID: 33732251 [TBL] [Abstract][Full Text] [Related]
5. Functional genomics highlights differential induction of antiviral pathways in the lungs of SARS-CoV-infected macaques. de Lang A; Baas T; Teal T; Leijten LM; Rain B; Osterhaus AD; Haagmans BL; Katze MG PLoS Pathog; 2007 Aug; 3(8):e112. PubMed ID: 17696609 [TBL] [Abstract][Full Text] [Related]
6. Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment. Lau SKP; Lau CCY; Chan KH; Li CPY; Chen H; Jin DY; Chan JFW; Woo PCY; Yuen KY J Gen Virol; 2013 Dec; 94(Pt 12):2679-2690. PubMed ID: 24077366 [TBL] [Abstract][Full Text] [Related]
7. Interferon and cytokine responses to SARS-coronavirus infection. Thiel V; Weber F Cytokine Growth Factor Rev; 2008 Apr; 19(2):121-32. PubMed ID: 18321765 [TBL] [Abstract][Full Text] [Related]
8. The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus Infection. Fehr AR; Channappanavar R; Jankevicius G; Fett C; Zhao J; Athmer J; Meyerholz DK; Ahel I; Perlman S mBio; 2016 Dec; 7(6):. PubMed ID: 27965448 [TBL] [Abstract][Full Text] [Related]
9. Differential immune activation profile of SARS-CoV-2 and SARS-CoV infection in human lung and intestinal cells: Implications for treatment with IFN-β and IFN inducer. Shuai H; Chu H; Hou Y; Yang D; Wang Y; Hu B; Huang X; Zhang X; Chai Y; Cai JP; Chan JF; Yuen KY J Infect; 2020 Oct; 81(4):e1-e10. PubMed ID: 32707230 [TBL] [Abstract][Full Text] [Related]
10. Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice. Nagata N; Iwata N; Hasegawa H; Fukushi S; Harashima A; Sato Y; Saijo M; Taguchi F; Morikawa S; Sata T Am J Pathol; 2008 Jun; 172(6):1625-37. PubMed ID: 18467696 [TBL] [Abstract][Full Text] [Related]
12. Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus. Devaraj SG; Wang N; Chen Z; Chen Z; Tseng M; Barretto N; Lin R; Peters CJ; Tseng CT; Baker SC; Li K J Biol Chem; 2007 Nov; 282(44):32208-21. PubMed ID: 17761676 [TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of SARS coronavirus infection using human lung epithelial cells: an in vitro model. Chan MC; Chan RW; Tsao GS; Peiris JS Hong Kong Med J; 2011 Dec; 17 Suppl 6():31-5. PubMed ID: 22147357 [No Abstract] [Full Text] [Related]
14. Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection. Channappanavar R; Fett C; Zhao J; Meyerholz DK; Perlman S J Virol; 2014 Oct; 88(19):11034-44. PubMed ID: 25056892 [TBL] [Abstract][Full Text] [Related]
15. Distinct severe acute respiratory syndrome coronavirus-induced acute lung injury pathways in two different nonhuman primate species. Smits SL; van den Brand JM; de Lang A; Leijten LM; van Ijcken WF; van Amerongen G; Osterhaus AD; Andeweg AC; Haagmans BL J Virol; 2011 May; 85(9):4234-45. PubMed ID: 21325418 [TBL] [Abstract][Full Text] [Related]
17. Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro. Yen YT; Liao F; Hsiao CH; Kao CL; Chen YC; Wu-Hsieh BA J Virol; 2006 Mar; 80(6):2684-93. PubMed ID: 16501078 [TBL] [Abstract][Full Text] [Related]
18. TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection. Iwata-Yoshikawa N; Okamura T; Shimizu Y; Hasegawa H; Takeda M; Nagata N J Virol; 2019 Mar; 93(6):. PubMed ID: 30626688 [TBL] [Abstract][Full Text] [Related]
19. MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV. Sheahan T; Morrison TE; Funkhouser W; Uematsu S; Akira S; Baric RS; Heise MT PLoS Pathog; 2008 Dec; 4(12):e1000240. PubMed ID: 19079579 [TBL] [Abstract][Full Text] [Related]
20. SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium. Sims AC; Burkett SE; Yount B; Pickles RJ Virus Res; 2008 Apr; 133(1):33-44. PubMed ID: 17451829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]